Disease-modifying therapies for Alzheimer’s disease (AD) heighten demand for scalable tools enabling primary care providers (PCPs) to detect cognitive impairment and triage patients for appropriate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results